Extracting Omega-3 Fish Oil from Fatty Fish — The Marine Fatty Acids That Built the Brain

Omega-3 fatty acids originate in marine phytoplankton — diatoms and dinoflagellates that synthesize EPA and DHA as structural components of their cell membranes, where these highly flexible fatty acids maintain membrane fluidity in cold ocean water. Zooplankton (copepods, krill) graze on phytoplankton and accumulate omega-3s. Small pelagic fish (anchoveta, sardine, menhaden, herring) eat zooplankton, concentrating the fatty acids in their body oil and liver. Larger predatory fish accumulate even higher levels. Humans cannot efficiently synthesize EPA and DHA from plant-based alpha-linolenic acid — dietary intake from marine sources is essential.

The global fish oil industry processes approximately 20 million tonnes of fish annually. Peruvian anchoveta (Engraulis ringens) is the single largest source, caught in the Humboldt Current upwelling zone off Peru and Chile. Atlantic menhaden (Brevoortia tyrannus) dominates North American production. European sources include herring (Clupea harengus), mackerel (Scomber scombrus), sprat, and sandeel. Antarctic krill (Euphausia superba) is an emerging source with naturally low contaminant levels. Each species has a distinct fatty acid profile — anchoveta averages 17% EPA and 9% DHA, while tuna oil is higher in DHA (25%) than EPA (6%).

Fish oil is produced by the wet reduction (wet rendering) process. Whole fish or processing waste is cooked in continuous steam cookers at 95-100°C for 15-20 minutes to coagulate protein and rupture fat cells. The cooked mass is pressed in twin-screw presses to separate liquid (press liquor) from solid (press cake used for fish meal). The press liquor passes through decanters and disc-stack centrifuges that separate it into crude fish oil, stickwater (aqueous protein), and fine solids. A modern fish meal factory processes 500-2,000 tonnes of raw fish per day.

Crude fish oil undergoes multi-step refining. Degumming with citric acid removes phospholipids. Alkali neutralization with sodium hydroxide removes free fatty acids as soap stock. Bleaching with activated earth adsorbs pigments and some contaminants. Winterization at 0°C crystallizes and removes saturated fats, increasing the omega-3 concentration. Deodorization under high vacuum (2-4 mbar) at 180-250°C strips volatile off-flavors. Activated carbon treatment removes environmental contaminants including dioxins, PCBs, and heavy metals to levels far below regulatory limits.

Pharmaceutical-grade omega-3 concentrates are produced by molecular (short-path) distillation. Fish oil triglycerides are first converted to ethyl esters by transesterification with ethanol. The ethyl esters are then separated by molecular distillation under extreme vacuum (0.001 mbar) — the different molecular weights of EPA-EE (330 Da) and DHA-EE (356 Da) cause them to evaporate at slightly different rates across a very short path. This produces concentrates containing 60-90% total EPA+DHA, compared to 30% in natural fish oil. The ethyl esters can be reconverted to triglyceride form for better bioavailability.

EPA (eicosapentaenoic acid, 20:5n-3) is a 20-carbon fatty acid with 5 double bonds. It is the precursor to series-3 prostaglandins and resolvins — signaling molecules that actively resolve inflammation. EPA competes with arachidonic acid (20:4n-6) for the cyclooxygenase and lipoxygenase enzymes, shifting the balance from pro-inflammatory to anti-inflammatory mediators. DHA (docosahexaenoic acid, 22:6n-3) is a 22-carbon chain with 6 double bonds. DHA constitutes 40% of polyunsaturated fatty acids in the brain and 60% in the retina. Its extreme flexibility allows rapid conformational changes in membrane proteins critical for neurotransmission and phototransduction.

The cardiovascular benefits of omega-3s were first observed in Greenlandic Inuit populations in the 1970s by Bang and Dyerberg, who noted low heart disease rates despite a high-fat marine diet. The GISSI-Prevenzione trial (1999) showed 1 g/day of EPA+DHA reduced cardiovascular death by 20% in post-heart-attack patients. The REDUCE-IT trial (2019) found 4 g/day of high-purity EPA (icosapent ethyl) reduced major cardiovascular events by 25%. DHA supplementation during pregnancy supports fetal brain and eye development. Evidence for cognitive decline prevention remains inconclusive.

The fish oil industry depends on sustainable fishery management. Peruvian anchoveta is managed by IMARPE with strict quotas based on biomass surveys — catches have fluctuated between 3-8 million tonnes annually. El Niño events collapse catches by warming surface waters and disrupting upwelling. The Marine Stewardship Council (MSC) certifies sustainable fisheries. Antarctic krill harvesting is regulated by CCAMLR with precautionary catch limits. Algal oil (from fermented Schizochytrium or Crypthecodinium microalgae) is a growing alternative that bypasses the marine food chain entirely, producing DHA directly without fish.

Microalgae are the original source of marine omega-3s. Industrial production ferments heterotrophic algae (Schizochytrium sp.) in stainless steel bioreactors at 25-30°C using glucose as carbon source — no sunlight needed. The algae accumulate DHA at 30-50% of dry cell weight. After fermentation, cells are lysed mechanically or enzymatically, and oil is extracted with hexane or supercritical CO₂. Algal DHA oil is vegan, free of ocean contaminants, and environmentally efficient. DSM (now dsm-firmenich) and Corbion are the major producers, supplying infant formula and supplements worldwide.

Record omega-3 fish oil key data: EPA (20:5n-3) and DHA (22:6n-3) are the principal marine omega-3 fatty acids, concentrated in cold-water fish at 15-30% of total lipids. Global fish oil production is approximately 1 million tonnes per year. The omega-3 story traces a line from microscopic phytoplankton to the human brain — these ancient molecules that evolved to keep cell membranes fluid in freezing ocean water turned out to be essential for the most complex structure in biology: the nervous system.